Tuesday, September 2, 2014

Top 10 Managed Healthcare Companies To Invest In 2014

Consumers added more than $32 billion in revolving debt in 2012, a recent CardHub.com study says. Overall, the U.S. populace owed credit card issuers more than $830 billion at the end of last year.

As good as that must be for the likes of Citigroup (NYSE: C  ) , which has seen sharp increases in consumer banking profits over the past two years, rising debt levels suggest that everyday shoppers haven't fared as well, says Tim Beyers of Motley Fool Rule Breakers and Motley Fool Supernova.

Fortunately, the indebted can take several practical steps to dig out. Principal among them, says Tim, who has also struggled with debt, is to use cash or charge cards as much as possible. That way, you're forced to pay your bill monthly.

Do you agree? Please watch the video to get two more of Tim's ideas, and then leave a comment to let us know the best financial advice you've received in your own battle with debt.

If you're an investor who prefers returns to rhetoric, you'll want to read The Motley Fool's new free report, "5 Dividend Myths ... Busted!" In it, you'll learn which stocks provide premium growth and whether bigger dividends are better. Click here to keep reading.��

Hot Tech Companies To Buy Right Now: FutureFuel Corp. (FF)

FutureFuel Corp., through its subsidiary, FutureFuel Chemical Company, engages in the manufacture and sale of specialty chemicals and bio-based products primarily in the United States. The company operates in two segments, Chemicals and Biofuels. The Chemicals segment provides custom chemical manufacturing services for specific customers, such as bleach activators for detergent and consumer products manufacturers; proprietary herbicide and intermediates for life sciences companies; agrochemicals; and industrial and consumer products, such as cosmetics and personal care products, ink colorants, adhesion promoters, polymer additives, polymer and specialty dyes, specialty polymers, photographic and imaging chemicals, and food additives. This segment also manufactures and sells a range of performance chemicals, including a family of polymer (nylon) modifiers and small-volume specialty chemicals for various applications; a family of acetal-based solvents, consisting of diethoxy methane, dimethoxymethane, dibutoxymethane, and glycerol formal; and phenol sulfonic acid that build on sulfonations technology. Its chemical products are used in various markets and end uses, including detergents, agrochemicals, automotive, photographic imaging, coatings, nutrition, and polymer additives. The Biofuels segment produces and sells biodiesel, as well as petrodiesel in blends with or without biodiesel. This segment also operates a granary in central Arkansas that involves in the purchase and sale of agricultural commodities, primarily soybeans, rice, and corn. This segment markets its biodiesel products by truck and rail directly to customers. FutureFuel Corp. was formerly known as Viceroy Acquisition Corporation and changed its name to FutureFuel Corp. in 2006. FutureFuel Corp. was incorporated in 2005 and is based in St. Louis, Missouri.

Advisors' Opinion:
  • [By Brian Pacampara]

    What: Shares of chemical and biofuels manufacturer FutureFuel (NYSE: FF  ) soared 20% on Tuesday after its quarterly results impressed Wall Street.

  • [By Maxx Chatsko]

    3. Focus on efficiency
    A combination of factors plays a role in efficiently producing biodiesel. FutureFuel (NYSE: FF  ) , which owns an annual capacity of 59 million gallons to complement its niche chemical business, relies heavily on location. The company's two biorefineries don't have a nationwide infrastructure to aid in getting product to the market and are dependent on rail and barge access. Despite the FutureFuel's amazing progress is improving its process -- annual capacity jumped from just 35 million gallons in 2011 to 59 million gallons today -- the company admits that its relatively small operations may cease to exist given changes in feedstock prices, government mandates, and tax credits. �

  • [By Monica Gerson]

    FutureFuel (NYSE: FF) surged 21.01% to $21.25 in the pre-market session after the company reported a rise in its fourth-quarter earnings. FutureFuel posted its quarterly profit of $0.61 per share, versus a year-ago profit of $0.15 per share.

Top 10 Managed Healthcare Companies To Invest In 2014: Rosetta Genomics Ltd (ROSG)

Rosetta Genomics Ltd., incorporated on March 9, 2000, is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product - miRview lung. As of December 31, 2011, the Company launched five tests based on its five microRNA technologies: miRview mets; miRview mets2; miRview squamous; miRview meso, and miRview lung.

Rimonim Consortium

In January 2011, the Company joined the Rimonim Consortium, which is supported by the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of the State of Israel, or the OCS. The purpose of the consortium is to develop RNA interference, or RNAi, -based therapeutics.

Rosetta Green

Rosetta Green Ltd. is an Israeli subsidiary of the Company, which was established to leverage its capabilities into the areas of cleantech and plant biotech by using its microRNA technologies to develop plants and algae more suitable for various applications, such as feedstocks for biofuels and agriculture. Research at the Rosetta Green project has been shown to develop algal strains with oil content, to discover potential novel microRNAs from commercially-important algae and to identify drought-regulated microRNAs in plants.

The Company competes with Pathwork Diagnostics, Inc., Biotheranostics, Inc., Combimatrix Corporation, Alnylam Pharmaceuticals, Inc., Asuragen Inc., Exiqon A/S, Life Technologies Corporation, Isis Pharmaceuticals, Merck & Co., Inc., Santaris Pharma A/S, and Regulus Therapeutics.

Advisors' Opinion:
  • [By Peter Graham]

    The Q3 2014 earnings report for molecular diagnostic company Myriad Genetics, Inc (NASDAQ: MYGN) is due out after the market closes on Tuesday and things could get ugly since unlike potential diagnostic stock peers such as Rosetta Genomics Ltd (NASDAQ: ROSG) and mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX), it�� the most shorted stock on the Nasdaq with short interest of 52.07%. Aside from the Myriad Genetics earnings report, it should be said that Rosetta Genomics Ltd last reported earnings on March 31st and those�earnings were for the full year 2013 while�Quest Diagnostics reported Q1 2014 earnings on April 24th that were a disappointment due to restructuring costs and harsh winter weather. However, Myriad Genetics has been the more interesting stock as Medicare reimbursement rate increases and the lost of a court bid to block competition while a patent-infringement case is pending have sent its shares all over the place.

  • [By John Udovich]

    The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer with the overall costs of the disease topping $126 billion annually ��meaning there is a big market for small cap cancer diagnostic stocks like Rosetta Genomics Ltd. (NASDAQ: ROSG), Genetic Technologies Limited (NASDAQ: GENE) and MetaStat Inc (OTCBB: MTST) just in the US alone without considering global cancer figures. After all, catching and doing something about cancer early on is critical to increase survival rates and bring down the cost of treatment. With that in mind, here are three small cap cancer diagnostic stocks helping to lead the fight to diagnose and stop cancer:

  • [By John Udovich]

    Small cap cancer diagnostic stock�Myriad Genetics, Inc (NASDAQ: MYGN) jumped to a five year high on Wednesday�thanks to good�news that the�government will be paying a heftier reimbursement for its main test than previously feared, meaning its worth taking a closer look at the stock along with small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should also mention that Myriad Genetics has been in our SmallCap Network Elite Opportunity (SCN EO) portfolio since early February and we are now up some 32.5% since then ��thanks in part to the shorts being put in a short squeeze.

Top 10 Managed Healthcare Companies To Invest In 2014: Lennox International Inc (LII)

Lennox International Inc. (LII) is a provider of climate control solutions. The Company designs, manufactures and markets a range of products for the heating, ventilation, air conditioning and refrigeration (HVACR) markets. Its products and services are sold through multiple distribution channels under brand names, including Lennox, Armstrong Air, Ducane, Bohn, Larkin, Advanced Distributor Products, Service Experts and others. The Company operates in four segments: Residential Heating & Cooling, Commercial Heating & Cooling, Service Experts, and Refrigeration. On January 14, 2011, the Company acquired Kysor/Warren business from The Manitowoc Company. Kysor/Warren is a manufacturer of refrigerated systems and display cases for supermarkets throughout North America and is included in its Refrigeration Segment. In April 2012, it sold its Lennox Hearth Products business to Comvest Investment Partners IV.

Residential Heating & Cooling

The Company manufactures and markets a range of furnaces, air conditioners, heat pumps, packaged heating and cooling systems, and accessories. These products are available in a range of designs, and at a range of price points, and provide a range of home comfort systems. Its advanced distributor products (ADP) operation builds evaporator coils and air handlers under the Advanced Distributor Products brand, as well as the Lennox, brand. ADP sells their own ADP branded evaporator coils to HVAC distribution, comprising over 400 wholesale distributors across North America, as well as, a range of evaporator coils for Allied Air Enterprise.

The Company�� hearth products include factory-built gas, wood-burning and electric fireplaces; free standing wood-burning, pellet and gas stoves; wood-burning, pellet and gas fireplace inserts; gas logs, venting products and accessories. Its fireplaces are built with a blower or fan option. It markets its hearth products under the Lennox, Superior, Country Collection and Security Chimneys brand names.

!

The Company competes with United Technologies Corp., Goodman Global, Inc., Ingersoll-Rand plc, Paloma Co., Ltd., Johnson Controls, Inc., Daiken, Nordyne, HNI Corporation and Monessen Hearth Company.

Commercial Heating & Cooling

In North America, the Company manufactures and sells unitary heating and cooling equipment used in light commercial applications, such as low-rise office buildings, restaurants, retail centers, churches and schools. Its product offerings for these applications include rooftop units ranging from 2 to 50 tons of cooling capacity and split system/air handler combinations, which range from 1.5 to 20 tons of cooling capacity. These products are distributed through commercial contractors and directly to national account customers.

In Europe, the Company manufactures and sells unitary products, which range from 2 to 70 tons of cooling capacity, and applied systems with up to 200 tons of cooling capacity. Its European products consist of small package units, rooftop units, chillers, air handlers and fan coils, which serve medium-rise commercial buildings, shopping malls, other retail and entertainment buildings, institutional applications and other field-engineered applications. It manufactures heating and cooling products in several locations in Europe and markets these products through both direct and indirect distribution channels in Europe, Russia, Turkey and the Middle East.

The Company competes with United Technologies Corp., Ingersoll-Rand plc, Johnson Controls, Inc., AAON, Inc. and Daikin Industries, Ltd.

Service Experts

The Company sells a range of its manufactured equipment, parts and supplies, and third-party branded products. It also has Lennox National Account Services business, which is providing service and preventive maintenance to commercial national account customers. It uses a portfolio of management procedures and practices, including standards for customer service, common informa! tion tech! nology systems and financial controls, a national accounting center and an inventory management program.

The Company competes with Direct Energy, Sears and American Residential Services.

Refrigeration

The Company manufactures and markets equipment for the global commercial refrigeration markets under the Heatcraft Worldwide Refrigeration name. It sells these products to distributors, installing contractors, engineering design firms, original equipment manufacturers and end-users. Its commercial refrigeration products for the North American market include condensing units, unit coolers, fluid coolers, air-cooled condensers, compressor racks and air handlers. These products are sold for refrigeration applications to preserve food and other perishables, and are used by supermarkets, convenience stores, restaurants, refrigerated warehouses and distribution centers. As part of the sale of commercial refrigeration products, it provides application engineering for consulting engineers, contractors and others. It also sells products for non-food and various industry applications, such as telecommunications, dehumidification and medical applications.

In international markets, the Company manufactures and markets refrigeration products, including condensing units, unit coolers, air-cooled condensers, fluid coolers, compressor racks and industrial process chillers. The Company has manufacturing locations in Germany, France, Brazil and China. In Australia and New Zealand, it is a wholesale distribution business serving the refrigeration and HVAC industry. It also owns a 50% interest in a joint venture in Mexico, which produces unit coolers, air-cooled condensers, condensing units and compressor racks. It also owns an 8% stock interest in a manufacturer in Thailand, which produces compressors for use in its products and for other HVACR customers.

The Company competes with Hussman Corporation, Emerson Electric Co., United Technologies Corp., GEA Group,! Alfa Lav! al and Sanyo Electric Co., Ltd.

Advisors' Opinion:
  • [By Monica Gerson]

    Lennox International (NYSE: LII) is projected to report its Q3 earnings at $1.28 per share on revenue of $877.87 million.

    ManpowerGroup (NYSE: MAN) is expected to report its Q3 earnings at $1.08 per share on revenue of $5.08 billion.

Top 10 Managed Healthcare Companies To Invest In 2014: Simmons First National Corp (SFNC)

Simmons First National Corporation is a multi-bank financial holding company. As of December 31, 2011, the Company had total loans of $1.7 billion, deposits of $2.7 billion and equity capital of $408 million. As of December 31, 2011, it owned eight community banks, which are located throughout Arkansas and conduct its operations through 88 offices, of which 84 are branches, or financial centers, located in 47 communities in Arkansas, Missouri and Kansas. Its community banks are supported by its subsidiary bank, Simmons First National Bank (SFNB or lead bank), which allows its community banks to provide products and services, such as a bank-issued credit card. As of December 31, 2011, SFNB had total loans of $0.9 billion and total deposits of $1.5 billion. Simmons First Trust Company N.A., a wholly owned subsidiary of SFNB, performs the trust and fiduciary business operations for SFNB and for the Company. Simmons First Investment Group, Inc., a wholly owned subsidiary of SFNB, is a broker-dealer and performs the broker-dealer operations for SFNB. Its subsidiary banks provide complete banking services to individuals and businesses throughout the market areas they serve. These banks offer consumer (credit card and other consumer), real estate (construction, single family residential and other commercial) and commercial (commercial, agriculture and financial institutions) loans, checking, savings and time deposits, trust and investment management services and securities and investment services. In September 2012, through its wholly owned bank subsidiary, Simmons First National Bank (SFNB), it acquired assets of Truman Bank of St. Louis from the Federal Deposit Insurance Corporation (the FDIC). In October 2012, SFNB acquired Excel Bank of Sedalia from the Federal Deposit Insurance Corporation. In November 2013, the Company acquired Metropolitan National Bank. Efffective November 25, 2013, the Company acquired Rogers Bancshares Inc.

Lending Activities

During the year ended December! 31, 2011, the Company�� loan portfolio, excluding loans covered by Federal Deposit Insurance Corporation (FDIC) loss share arrangements, averaged $1.621 billion. As of December 31, 2011, total loans, excluding loans covered by FDIC loss share arrangements, were $1.580 billion. The components of the loan portfolio were loans to businesses (commercial loans, commercial real estate loans and agricultural loans) and individuals (consumer loans, credit card loans and single-family residential real estate loans).

Consumer loans consist of credit card loans, student loans and other consumer loans. As of December 31, 2011, consumer loans were $346.6 million or 21.9% of total loans. As of December 31, 2011, the student loan portfolio balance was $47.4 million. As of December 31, 2011, student loans were 3% of total loans. Real estate loans consist of construction loans, single family residential loans and commercial loans. As of December 31, 2011, real estate loans were $1.001 billion or 63.4% of total loans. As of December 31, 2011, its construction and development (C&D) loans represent 7% of its loan portfolio and commercial real estate (CRE) loans (excluding C&D) represent 34% of its loan portfolio. Commercial loans consist of commercial loans and agricultural loans. As of December 31, 2011, commercial loans were $227.2 million or 14.4% of total loans.

Investment Activities

Securities within the portfolio are classified as either held-to-maturity, available-for-sale or trading. Held-to-maturity securities include any security for which management has the positive intent and ability to hold until maturity, are carried at historical cost, adjusted for amortization of premiums and accretion of discounts. As of December 31, 2011, held-to-maturity and available-for-sale investment securities were $525.4 million and $172.2 million. As of December 31, 2011, $312.8 million, or 59.5%, of the held-to-maturity securities were invested in United States Treasury securities and o! bligation! s of the United States government agencies, 60.0% of which will mature in less than five years. In the available-for-sale securities, $153.6 million, or 89.2%, were in the United States Treasury and the United States government agency securities.

Sources of Fund

Deposits are the Company�� source of funding for earning assets and are developed through its network of 84 financial centers. It offers a range of products designed to attract and retain customers with a continuing focus on developing core deposits. Its core deposits consist of all deposits excluding time deposits of $100,000 or more and brokered deposits. As of December 31, 2011, core deposits comprised 86.5% of its total deposits. As of December 31, 2011, its total deposits were $2.65 billion. As of December 31, 2011, non-interest bearing transaction accounts were $532.3 million. As of December 31, 2011, interest bearing transaction and savings accounts were $1.240 billion. As of December 31, 2011, it had $20.6 million of brokered deposits.

As of December 31, 2011, Federal funds purchased and securities sold under agreements to repurchase were $114.8 million. As of December 31, 2011, its other short-term borrowings, consisting of the United States Treasury Tax and Loan (TT&L) Notes and short-term Federal Home Loan Bank (FHLB) borrowings were $272,000. As of December 31, 2011, its long-term debt was $120.8 million. As of December 31, 2011, the outstanding long-term debt balance includes $89.9 million in FHLB long-term advances and $30.9 million of trust preferred securities.

Advisors' Opinion:
  • [By Tim Melvin]

    Finally, Simonds First National Corp. (Nasdaq: SFNC) is a Midwestern bank with 96 branches in Arkansas, Missouri, and Kansas. The stock has been strong this year, but CEO George Makris thinks there is additional upside ahead for the shares.

Top 10 Managed Healthcare Companies To Invest In 2014: Vanguard Intermediate Term Bond ETF (BIV)

Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximate the full Index in terms of key risk factors and other characteristics. All of the Fund�� investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund�� investment advisor is The Vanguard Group, Inc. Advisors' Opinion:
  • [By GURUFOCUS]

    In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
    Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
    - Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
    - Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
    - Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%

Top 10 Managed Healthcare Companies To Invest In 2014: Danieli & C Officine Meccaniche SpA (DAS)

Danieli & C Officine Meccaniche SpA is an Italy-based company primarily engaged in industrial sector. The Company designs, manufactures, sales and makes installation of machines and plants for the metallurgical industry. The Company's portfolio includes mines; pellet production plants; blast furnaces; direct reduction equipment; machinery for the treatment of scrap metal; steelworks for production of liquid steel; continuous casting machinery for blooms, billets and slabs; rolling mills for long products, seamless tubes and flat products; production lines for welded tubes and flat products; plants for secondary processing, such as peeling, rolling and drawing; forging presses and manipulators; extrusion presses for ferrous and non-ferrous metals; plants for longitudinal and transversal cutting; automation and control systems, and cranes and lifting equipment. It is also active in the production and sale of special steel for automotive, machine tools and railway industry, among others. Advisors' Opinion:
  • [By Damian Illia]

    Crown Castle has acquired recently the privately held company NextG Networks Inc., largest provider of outdoor Distributed Antenna Systems (DAS), with more than 7,000 DAS plus another 1,500 nodes in the pipeline, and over 4,600 miles fiber-optic cable�� transmission rights. Through this addition, the company has improved greatly its DAS network across 26 United States metropolitan areas. As NextG has only 1.7 tenants per network on an average and thus underutilizing its capacity, Crown Castle will increase customers with no integration and rearrangement costs. Another company�� big move was the acquisition of 9,700 wireless towers from AT&T Inc. (T) Located in the top 100 markets in the U. S. T-Mobile is likely to maintain its infrastructure in these towers for the next 10 years. On top of all, the recent conversion of business into a REIT has represented long term benefits for the company in terms of tax savings and enhancing shareholders��wealth.

  • [By GURUFOCUS]

    EMC�� products ��both hardware and software - are litearlly a geek�� wonderland alphabet soup, which include Storage Area Network (SAN), Network Attached Storage (NAS), Direct Attached Storage (DAS), Virtual SAN, All-Flash XtremIO, Atmos, Avamar, �Data Domain, Isilon, Pivotal, ViPR Software Defined Storgae, VMAX, VNX, VNXe, VPLEX, VSPEX (none of these are typos).� Information storage makes up 70% of revenues and virtualization 23% of revenues.� Products generate 55% of revenues.� Services generate 45% of revenues.� The Company�� gross profit split is approximaltey 67% data storage and 31% virtualization.

Top 10 Managed Healthcare Companies To Invest In 2014: Cutera Inc. (CUTR)

Cutera, Inc., a medical device company, engages in the research, design, development, manufacture, marketing, sale, and service of laser and other energy based aesthetics systems for practitioners worldwide. The company offers a range of non-invasive laser and intense pulsed light products for use in the treatment of cosmetic vascular conditions, hair removal, vascular lesions, skin rejuvenation, onychomycosis or toenail fungus, pigmented lesions, laser skin toning, tattoo removal, cutaneous lesions, fine wrinkles, diffuse redness, rosacea, skin texture, and pore size, as well as for non-invasive body contouring applications. It primarily serves plastic surgeons, dermatologists, gynecologists, primary care physicians, family practitioners, physicians offering aesthetic treatments in non-medical offices, podiatrists, and other qualified practitioners. The company sells and markets its products through its direct sales force and distributors, as well as sells hand piece refi lls through the Internet. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Advisors' Opinion:
  • [By John Udovich]

    Large cap serial acquirer�Valeant Pharmaceuticals International Inc (NYSE: VRX) is teaming up with activist investor�Bill Ackman to pursue large cap Botox maker Allergan, Inc (NYSE: AGN), but stocks like Cutera, Inc (NASDAQ: CUTR), Cynosure, Inc (NASDAQ: CYNO), PhotoMedex Inc (NASDAQ: PHMD) and Syneron Medical Ltd (NASDAQ: ELOS)�actually offer investors more exposure to the growing anti aging and aesthetics market (Note: See my recent article: These Small Caps Seek to Treat Your Crow�� Feet and Double Chin (RVNC & KYTH)). To begin with, Valeant Pharmaceuticals International has a wide focus on neurology, dermatology and infectious diseases�but acquiring the maker of Botox won�� be its first foray into the aesthetic market�because earlier this year, the company completed its acquisition of Solta Medical Inc (NASDAQ: SLTM) -�a designer, developer, manufacturer and marketer of�energy-based medical device systems for aesthetic applications.�And while�Allergan, Inc may be most well known for Botox, its actually a pretty big�company focused on a diverse range of areas, including ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics���meaning the following stocks offer investors better exposure to the aesthetics market:

No comments:

Post a Comment